Ayati Devices Secures $1.6M in Funding Led by Inflexor Ventures to Advance Health Solutions

Ayati Devices has raised ₹15 crore, or about US$1.6 million, in a Pre-Series A funding round led by Inflexor Ventures.

The investment will help the firm commercialize its diagnostic technologies, expand manufacturing, enter new international markets, and accelerate research in AI-enabled diagnostics.

India's Growing Need for Better Medical Technology

Many people in India face health challenges that could benefit from better diagnostic tools.

Diabetes affects more than 90 million Indians and can lead to serious foot complications if not detected early.

Funding like this supports local innovation in medical technology and expands access to diagnostic care.

Companies in this space work to bring screening beyond tertiary hospitals and into primary care centres and diabetes clinics.

What This Means for the Future of Healthcare

Expanded manufacturing and international operations will support Ayati's efforts to scale its diagnostic technologies.

Regulatory work will help the company secure additional approvals as it expands into new markets.

The funding will also support AI-enabled diagnostics, research and development, and the company's broader product portfolio.

Ayati has deployed more than 10,000 devices across 30+ countries and plans to deepen its presence across Europe, the US, the Middle East, Southeast Asia, Australia, and Latin America.